Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
Immunai, Inc.

August 2026

Immunai, Inc. Market Share Analysis for August 2026

We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Year Founded2018
Employees51 - 200
Annual Revenue$15M - $25M
immunai.com
Immunai, Inc.
Immunai, Inc. (including company regionals)
  • immunai.com
    immunai.com
See more website traffic and engagement information

Immunai, Inc. Revenue up to August 2026 is 15M - 25M

revenue generated by Immunai, Inc. top domains

Immunai, Inc. top domains revenue over 3 years

Revenue for Immunai, Inc. top domains


Total visits to Immunai, Inc.'s top domains

Understand Immunai, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Immunai, Inc.'s top domains

Analyze Immunai, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Immunai, Inc.'s top domains

See how Immunai, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Immunai, Inc.

These are the website technologies, by industry, used by Immunai, Inc. top domains

Advertising (5)

DoubleClick

DoubleClick

Widget (4)

reCAPTCHA

reCAPTCHA

Conversion & Analytics (3)

Google Analytics

Google Analytics

Audio Video Media (2)

YouTube

YouTube

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Immunai, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImmunai Inc. partnered with Boehringer Ingelheim on Jun 25th '26.Immunai signs up to $15 million research pact with Boehringer Ingelheim.
NewsImmunai partnered with AstraZeneca on May 7th '26.Today, Immunai is doing just that by announcing a major expansion of its collaboration with AstraZeneca,

See all Immunai, Inc. signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.